Biomedical Research Related Content

Scientists at the University of Tsukuba reveal that brain refreshing takes place during the dreaming phase of sleep, aka rapid eye movement (REM) sleep.

L. Maximilian Buja, MD, Professor of Pathology and Laboratory Medicine at McGovern Medical School, The University of Texas Health Science Center at Houston, turns the spotlight onto medical education both past and present.

Open Bionics opens its first clinic in the UK to deliver 3D printed bionic arms for amputees.

A new study by the University of Eastern Finland finds that a blood test could help to diagnose patients with frontotemporal dementia.

The Henry Royce Institute is enhancing the UK’s position as an international leader in the field of biomedical materials, systems and devices.

The SIB Swiss Institute of Bioinformatics is an internationally recognised non-profit organisation dedicated to biological and biomedical data science.

Scientists are creating a blood test that can quickly diagnose heart attacks - by looking for the "unique fingerprint" of a heart attack.

Mutlu Özcan, Prof. Dr Dr h.c., PhD from the University of Zürich, highlights Reconstructive Dentistry through new biomaterials and technologies, including the associated changes and challenges.

Professor Darren Griffin reflects on how patients in fertility clinics should interpret the scientific evidence base when even the experts can’t seem to agree.

Michael Morrison, Senior Researcher in Social Science at the University of Oxford, illustrates the importance of emerging biomedical innovations in the UK.

The research team believe that some people have a genetic predisposition that increases likelihood of severe COVID, which may be crucial to understanding how mutations could change outcomes.

The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.

The New Jersey-based drugmaker created a COVID-19 vaccine that works at 66% efficiency in one dose, which they have sent to the EU for approval.

Targeted neuromodulation may be a future method to help those with severe, untreatable depression - traditionally, this is used to correct misfiring brain circuits in people with epilepsy or Parkinson's.

Jane C Khoury & Shelley R Ehrlich from Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, highlight the consequences of foetal development in a “sweet” uterus – including the short- and long-term transgenerational outcomes.

Here, Dr Anju Vasudevan, discusses two distinct vascular therapies in the prenatal, postnatal, and adult brain to combat mental illness.

Scientists from Trinity College Dublin have developed a new gene therapy for an eye disease that leads to progressive loss of vision.

Researchers at University College London have found that COVID-19 mutations do not make the virus more likely to spread, as previously feared.

Dr Ganesan Baranidharan, consultant in anaesthesia and pain medicine at the Leeds Teaching Hospitals NHS Trust, explains the power of neuromodulation for managing chronic pain and explains why comprehensive evidence is needed.

Researchers at the University of Illinois investigated how the mutation of COVID-19 is making the virus stronger.